Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
27.28
-2.34 (-7.90%)
Mar 31, 2025, 9:47 AM EDT - Market open
Kymera Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$56.69
Upside
+107.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $52 | Strong Buy | Initiates | $52 | +90.62% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $54 → $60 | Strong Buy | Maintains | $54 → $60 | +119.94% | Feb 28, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $60 | Buy | Reiterates | $60 | +119.94% | Jan 21, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $60 | Buy | Maintains | $60 | +119.94% | Dec 27, 2024 |
| BTIG | BTIG | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +119.94% | Dec 10, 2024 |
| BMO Capital | BMO Capital | Hold Initiates $55 | Hold | Initiates | $55 | +101.61% | Dec 6, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $38 → $57 | Hold → Buy | Upgrades | $38 → $57 | +108.94% | Dec 2, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $65 | Buy | Initiates | $65 | +138.27% | Nov 18, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $49 | Hold | Maintains | $45 → $49 | +79.62% | Nov 6, 2024 |
| UBS | UBS | Strong Buy Maintains $80 → $74 | Strong Buy | Maintains | $80 → $74 | +171.26% | Nov 4, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $54 → $53 | Strong Buy | Reiterates | $54 → $53 | +94.28% | Nov 1, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $52 → $56 | Buy | Maintains | $52 → $56 | +105.28% | Sep 27, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $60 | Buy | Initiates | $60 | +119.94% | Sep 9, 2024 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $65 | Hold → Buy | Upgrades | $65 | +138.27% | Aug 26, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $34 → $45 | Hold | Maintains | $34 → $45 | +64.96% | Aug 14, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $30 → $38 | Hold | Maintains | $30 → $38 | +39.30% | Aug 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.